Leading Woman in Biopharmaceutical Giant
Reshma Kewalramani has created history by becoming the first woman to head a major American biopharmaceutical company with substantial revenues. Indian women have consistently marked their presence in fields like technology, science, and business both nationally and globally. In this collection of success stories, we’ll explore the achievements of an Indian woman who has accomplished remarkable feats abroad, making her country proud.
Reshma Kewalramani now holds the significant role of Chief Executive Officer and President at a biotech company located in Boston. Alongside, she serves on the board of directors of the Biomedical Science Careers Program and the Dean’s Advisory Board for the Boston University School of Medicine. She’s also been part of the first board of directors for the Kidney Health Initiative and is a Fellow of the American Society of Nephrology.
Born in Mumbai and moving to the United States at 11, Reshma Kewalramani pursued her medical degree at the Boston University School of Medicine. She also completed Harvard Business School’s General Management Program. Her medical journey began at Massachusetts General Hospital and Brigham and Women’s Hospital.
Reshma Kewalramani joined the company in 2017, initially serving as Chief Medical Officer and Executive Vice President of Global Medicines Development and Medical Affairs. An accomplished scientist, Kewalramani has dedicated her career to developing innovative medicines for patients, focusing on enhancing their lives.
Recognitions for Reshma Kewalramani include the Harvard Medical School Excellence in Teaching Award, and she’s been named one of the individuals revolutionizing healthcare by Business Insider. As of 2023, Reshma Kewalramani’s estimated net worth is 64.6 million dollars according to Wallmine.
Re-reported from the article originally published in Zee News
